Alison is the ABPI's Executive Director Commercial and is primarily responsible for all the Association’s work on pricing, including Pharmaceutical Price Regulation Scheme (PPRS), and value based pricing. Alison and her team work with industry, the Government, NICE, the NHS and other stakeholders to ensure that medicines’ true value is understood and assessed appropriately and that patients and the NHS can access the medicines they need when they need them.
Alison leads on the PPRS, and is responsible for consulting with all pharmaceutical companies, not just ABPI members, for the negotiation of the next UK medicines pricing scheme, which will come into effect from 2014.
Alison joined the ABPI in May 2009 from Quintiles - Innovex, where she held a series of top management roles, including European Managing Director of Innovex Medical Communications, Head of Innovex Global Operations and Managing Director of Innovex UK.
Before her MD roles, Alison was Operations Director for the Clinical Research and Health Management division and prior to this had a variety of roles in sales, marketing, medical, clinical research and human resources during 15 years at GlaxoSmithKline.
A pharmacist by training, she graduated from Nottingham University and began her career in hospital pharmacy.